SCHEMBL4098658

SCHEMBL4098658

CC[C@@H](C)c1cc(OC)c(OC)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.49
MAPK1 P28482 1/20 0.49
ACHE P22303 1/20 0.48
MAPT P10636 4/20 0.46
CYP3A4 P08684 1/20 0.46
CA9 Q16790 1/20 0.46
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
TUBB4A P04350 3/20 0.44
TUBB P07437 3/20 0.44
TUBA3C P0DPH7 3/20 0.44
TUBA1B P68363 3/20 0.44
TUBA4A P68366 3/20 0.44
TUBB4B P68371 3/20 0.44
TUBB3 Q13509 3/20 0.44
TUBB2A Q13885 3/20 0.44
TUBB8 Q3ZCM7 3/20 0.44
TUBA3E Q6PEY2 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10110894 1.00 PTGS2 (0.54) PTGS2L3MBTL1MAPK1ACHEMAPT
SCHEMBL2618698 1.00 PTGS2 (0.54) PTGS2L3MBTL1MAPK1ACHEMAPT
SCHEMBL8403278 0.88 PTGS2 (0.42) PTGS2L3MBTL1MAPK1ACHEMAPT
SCHEMBL24498543 0.86 PTGS2 (0.48) PTGS2L3MBTL1MAPK1ACHEMAPT
SCHEMBL12133486 0.84 PDE4A (0.42) PTGS2L3MBTL1MAPK1MAPTCYP3A4
SCHEMBL11233982 0.83 PTGS2 (0.45) PTGS2L3MBTL1MAPK1ACHEMAPT
SCHEMBL20373607 0.83 ALDH1A1 (0.43) MAPTALDH1A1LMNATP53ALOX12
SCHEMBL13375683 0.81 ALDH1A1 (0.41) PTGS2L3MBTL1MAPK1ACHEMAPT
SCHEMBL6721159 0.81 ALDH1A1 (0.45) ACHEMAPTCYP3A4CA9ALDH1A1
SCHEMBL14399655 0.80 CYP3A4 (0.48) PTGS2ACHECYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426432-B2 Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties UNIVERSITY OF CONNECTICUT (US) 2013-04-23 US disclosed
US-20090105287-A1 Inhibitors of Dihydrofolate Reductase With Antibacterial Antiprotozoal, Antifungal and Anticancer Properties UNIVERSITY OF CONNECTICUT (US) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105287-A1 Inhibitors of Dihydrofolate Reductase With Antibacterial Antiprotozoal, Antifungal and Anticancer Properties DHFR, DPYD, DHODH PTGS2 1784/4885L3MBTL1 2675/4885MAPK1 3218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.